Navigation Links
Small material, big impact
Date:2/14/2011

The European Commission's Joint Research Centre (JRC) has just launched the first European repository of nanomaterials with a representative range of 25 different types of reference nanomaterials. This will support safety assessment to ensure consumer protection and confidence in many innovative applications and products. Nanotechnology is one of today's most promising technological developments. By enabling a harmonised risk assessment the repository can contribute to the success of nanotechnology and its products. Standardised methodologies and materials are necessary to obtain worldwide comparable test results and to provide reliable data for policy and regulatory decision making.

Launching the repository officially today, Elke Anklam, Director of the JRC Institute for Health and Consumer Protection (IHCP), said: "This unique repository fosters standardisation in safety assessment and facilitates innovation by creating a common and consistent measurement framework for all stakeholders. This will both support international harmonisation bodies for standardising risk assessment as well as EU policy makers for regulatory issues."

Nanomaterials may offer a range of benefits over traditional materials and enable the development of innovative applications and products. For European industry to capitalise in the best sense from nanotechnologies, it is essential that the EU has a well-considered regulatory framework covering issues related to safe practices in the manufacturing process, consumer health, and protection of the environment.

Such a framework depends on harmonised and science based risk assessment. In order to ensure the comparability of the underlying data obtained in the many international test laboratories, the availability of representative reference nanomaterials is essential.

This first European repository of nanomaterials has been created by the JRC in response to needs for safety-assessment testing from experts in the major international standardisation bodies. The repository contains most types of nanomaterials currently assumed to be used in significant volumes in consumer products. Some 8000 test samples have already been distributed to European national authorities, EU-funded research projects, and have also been used in international scientific co-operation initiatives (such as the OECD Working Party on Manufactured Nanomaterials). The nanomaterials contained in the repository are produced in collaboration with the German Fraunhofer Institute for Molecular Biology and Applied Ecology (IME) under Good Laboratory Practice (GLP) conditions. The 25 types of material include carbon nanotubes, silver nanoparticles, titanium dioxide, cerium oxide, zinc oxide, bentonite, gold and silicon dioxide.


'/>"/>

Contact: Berta Duane
berta.duane@ec.europa.eu
39-033-278-9743
European Commission Joint Research Centre
Source:Eurekalert

Related biology technology :

1. Polaris Group and The Ludwig Institute for Cancer Research Ltd Initiate Phase 2 Trial of Amino-Acid Degrading Enzyme, ADI-PEG 20, in Patients with Small Cell Lung Cancer
2. New England Biolabs Develops Novel Small RNA NGS Protocol: Reagents Improve Yield and Decrease Adaptor-Dimer Formation
3. Alzheimers Drug Discovery Foundation Funds ALS Biopharma to Develop Small Molecules for Alzheimers Disease
4. Worlds smallest battery created at CINT nanotechnology center
5. Amylin Pharmaceuticals to Present at the Citi 7th Annual US Small/Mid Cap Conference
6. Nanogenerators grow strong enough to power small conventional electronics
7. Martek to Present at Upcoming Citi Small / Mid Cap Conference
8. Smaller is better in the viscous zone
9. Building a smaller, lighter future: Understanding polymer behaviors below 1 nanometer
10. YM BioSciences licensee Pulmokine awarded NIH funding to develop small molecule drugs for pulmonary hypertension
11. MabVax Therapeutics Receives Small Business Innovation Research Program Award from the National Cancer Institute
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2016)...  Bayer today announced that a Phase III ... (regorafenib) tablets for the treatment of patients with ... endpoint of a statistically significant improvement in overall ... and safety of regorafenib in patients with HCC ... The safety and tolerability were generally consistent with ...
(Date:5/4/2016)... (PRWEB) , ... May 04, 2016 , ... ... recent innovations in biotechnology to help treat hormonal and stress related hair loss. ... has captured the hearts of key opinion leaders in the medical and salon ...
(Date:5/3/2016)... , ... May 03, 2016 , ... ... at Boston CEO 2016 on May 31st and June 1st at The Four ... for leading executives in the life sciences, offering exclusive access to key decision ...
(Date:5/3/2016)... 2016 - And Other Rising ... of Those Competitor Biologics  - Biosimilar Drug ... Prospects ,  Who are the most important ... are their sales potentials? Discover, in our updated survey, ... opportunities and revenue forecasting. Visiongain,s ...
Breaking Biology Technology:
(Date:4/26/2016)... DUBLIN , April 27, 2016 ... of the  "Global Multi-modal Biometrics Market 2016-2020"  report ... ) , The analysts forecast ... a CAGR of 15.49% during the period 2016-2020.  ... a number of sectors such as the healthcare, ...
(Date:4/14/2016)... 2016 BioCatch ™, the ... announced the appointment of Eyal Goldwerger as ... Goldwerger,s leadership appointment comes at a time of ... deployment of its platform at several of the world,s ... discerns unique cognitive and physiological factors, is a winner ...
(Date:3/29/2016)... , March 29, 2016 ... "Company") LegacyXChange "LEGX" and SelectaDNA/CSI Protect are pleased to ... ink used in a variety of writing instruments, ensuring ... of originally created collectibles from athletes on LegacyXChange will ... analysis of the DNA. Bill Bollander ...
Breaking Biology News(10 mins):